Skip to main content

Table 1 Summary of identified health resources and cost estimates

From: A cost utility analysis alongside a cluster-randomised trial evaluating a minor ailment service compared to usual care in community pharmacy

 

MAS CPa (n = 323)

Mean (SDb) (€)

UC CPa (n = 485)

Mean (SDb) (€)

P-value

Medication costc

7.67 (2.62)

7.88 (3.11)

0.331

Consultation costd

1.55 (0.95)

1.13 (1,05)

0.000

Training cost

0.05 (0.00)

0.00 (0.00)

NA

Infrastructure and maintenance cost

0.53 (0.00)

0.53 (0.00)

NA

Total cost consultation in CP

9.80 (3.37)

9.54 (4.07)

0.012

Cost of other visits to GP or ED

11.61 (13.19)

4.94 (9.35)

0.001

Total coste

21.41 (30.39)

14.48 (23.38)

0.001

  1. aUC CP Usual Care Community Pharmacy, MAS CP Minor Ailment Service Community Pharmacy
  2. bSD: Standard Deviation
  3. cIn Spain, medication costs are paid by the patient
  4. dConsidering pharmacist role (supervisor/regular pharmacist): time used for pharmacist-patient consultation was 8.00 min (SD = 2.45) for a supervisor in MAS group, 5.35 min (SD = 3.20) for a regular pharmacist in MAS group, 6.57 min (SD = 3.90) for a supervisor in UC group and 4.95 min (SD = 3.85) for a regular pharmacist in UC group. Pharmacists in UC group were asked to document the consultation which is not part of usual care
  5. eFirst consultation in CP and other consultations during the 10 days studied were considered
  6. NA Not applicable